Search for anticonvulsant and analgesic active derivatives of dihydrofuran-2(3H)-one

Bioorg Med Chem. 2012 Nov 1;20(21):6533-44. doi: 10.1016/j.bmc.2012.08.037. Epub 2012 Aug 31.

Abstract

A series of derivatives of dihydrofuran-2(3H)-one (γ-butyrolactone, GBL) was synthesized and tested for anticonvulsant, neurotoxic and analgesic activity. In the anticonvulsant screening 10 lactones were effective in the maximal electroshock test (MES) at the highest doses (300 and 100 mg/kg, 0.5 h, ip, mice). Statistical analysis showed correlation between the anticonvulsant activity and relative lipophilicity parameters determined by experimental and computational methods (R(M0), ClogP and MlogP). Preliminary antinociceptive evaluation of selected derivatives revealed strong analgesic activity. The majority of the tested compounds showed high efficacy in animal models of acute pain (hot plate and writhing tests) and strong local anesthetic activity (modified tail immersion test). The obtained ED(50) values were comparable with such analgesics as acetylsalicylic acid and morphine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Butyrolactone / analysis*
  • 4-Butyrolactone / chemical synthesis
  • 4-Butyrolactone / chemistry*
  • 4-Butyrolactone / pharmacology
  • Analgesics / administration & dosage
  • Analgesics / chemistry*
  • Analgesics / pharmacology*
  • Anesthetics, Local / administration & dosage
  • Anesthetics, Local / chemistry
  • Anesthetics, Local / pharmacology
  • Animals
  • Anticonvulsants / administration & dosage
  • Anticonvulsants / chemistry*
  • Anticonvulsants / pharmacology*
  • Dose-Response Relationship, Drug
  • Electroshock
  • Male
  • Mice
  • Pain
  • Pain Measurement / drug effects*

Substances

  • Analgesics
  • Anesthetics, Local
  • Anticonvulsants
  • 4-Butyrolactone